Recursion Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 39.78 M | $194.13 M | 10.28% | 9.53% |
| ARK INVESTMENT MANAGEMENT LLC | 11/12/2025 | 33.55 M | $163.70 M | 1.69% | 8.04% |
| BLACKROCK, INC. | 11/12/2025 | 31.74 M | $154.89 M | 11.87% | 7.60% |
| BAILLIE GIFFORD & CO | 10/31/2025 | 23.98 M | $117.02 M | -0.81% | 5.75% |
| STATE STREET CORP | 11/14/2025 | 18.27 M | $89.15 M | 63.41% | 4.38% |
| SOFTBANK GROUP CORP. | 11/14/2025 | 14.67 M | $71.58 M | 0.00% | 3.51% |
| KINNEVIK AB (PUBL) | 11/04/2025 | 13.43 M | $65.56 M | 0.00% | 3.22% |
| MUBADALA INVESTMENT CO PJSC | 11/14/2025 | 12.99 M | $63.37 M | 0.00% | 3.11% |
| MIC CAPITAL MANAGEMENT UK LLP | 11/14/2025 | 9.64 M | $47.06 M | 0.00% | 2.31% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 9.62 M | $46.97 M | 23.75% | 2.31% |
| NOVO HOLDINGS A/S | 11/14/2025 | 7.93 M | $38.70 M | -17.95% | 1.90% |
| NVIDIA CORP | 11/14/2025 | 7.71 M | $37.61 M | 0.00% | 1.85% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 10/27/2025 | 7.47 M | $36.43 M | -8.59% | 1.79% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 11/12/2025 | 7.47 M | $36.36 M | -8.59% | 1.79% |
| MORGAN STANLEY | 11/14/2025 | 7.29 M | $35.58 M | 28.13% | 1.75% |
| DATA COLLECTIVE IV GP, LLC | 11/14/2025 | 5.94 M | $28.99 M | 0.00% | 1.42% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 5.39 M | $26.30 M | 68.13% | 1.29% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 4.20 M | $20.48 M | -9.07% | 1.01% |
| DCVC OPPORTUNITY FUND II GP, LLC | 11/14/2025 | 3.95 M | $19.28 M | 0.00% | 0.95% |
| UBS GROUP AG | 11/13/2025 | 3.75 M | $18.32 M | -18.94% | 0.90% |
| EXOR CAPITAL LLP | 11/13/2025 | 3.68 M | $17.93 M | 0.00% | 0.88% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 3.45 M | $16.81 M | 33.05% | 0.83% |
| NORTHERN TRUST CORP | 11/14/2025 | 3.34 M | $16.29 M | 14.49% | 0.80% |
| FMR LLC | 11/13/2025 | 3.23 M | $15.76 M | -42.19% | 0.77% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 2.45 M | $11.96 M | 109.86% | 0.59% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 2.16 M | $10.55 M | 30.00% | 0.52% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 2.03 M | $9.93 M | -14.16% | 0.49% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.94 M | $9.48 M | 13.26% | 0.47% |
| FIRST TRUST ADVISORS LP | 11/12/2025 | 1.80 M | $8.77 M | -4.42% | 0.43% |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 11/05/2025 | 1.77 M | $8.66 M | 94.82% | 0.43% |
| PICTET & CIE (EUROPE) SA | 10/21/2025 | 1.63 M | $7.95 M | 100.00% | 0.39% |
| BARCLAYS PLC | 11/12/2025 | 1.55 M | $7.57 M | 33.10% | 0.37% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 1.37 M | $6.68 M | 26.68% | 0.33% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.35 M | $6.58 M | 2.60% | 0.32% |
| NUVEEN, LLC | 11/12/2025 | 1.28 M | $6.23 M | 4.14% | 0.31% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.26 M | $6.16 M | 11.53% | 0.30% |
| PEAK6 LLC | 11/14/2025 | 1.24 M | $6.03 M | -14.69% | 0.30% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.22 M | $5.97 M | -11.24% | 0.29% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.09 M | $5.32 M | 55.98% | 0.26% |
| COMPREHENSIVE FINANCIAL MANAGEMENT LLC | 11/14/2025 | 941.90 K | $4.60 M | 0.00% | 0.23% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 815.45 K | $3.98 M | 100.00% | 0.20% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 801.37 K | $3.91 M | 269.24% | 0.19% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/12/2025 | 750.19 K | $3.66 M | 110.63% | 0.18% |
| CAPITAL FUND MANAGEMENT S.A. | 11/13/2025 | 726.02 K | $3.54 M | 0.76% | 0.17% |
| JANE STREET GROUP, LLC | 11/14/2025 | 721.55 K | $3.52 M | 100.00% | 0.17% |
| LIONTRUST INVESTMENT PARTNERS LLP | 11/24/2025 | 702.39 K | $3.55 M | 0.00% | 0.17% |
| DIADEMA PARTNERS LP | 11/14/2025 | 698.40 K | $3.41 M | 0.00% | 0.17% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 11/10/2025 | 621.06 K | $3.03 M | -53.62% | 0.15% |
| SWISS NATIONAL BANK | 11/13/2025 | 620.60 K | $3.03 M | 9.61% | 0.15% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 11/13/2025 | 595.52 K | $2.91 M | 0.00% | 0.14% |
Recursion Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 401 institutional investors and hedge funds held shares of Recursion Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 39.78 M
ARK Investment Management LLC: 33.55 M
BlackRock, Inc.: 31.74 M
BAILLIE GIFFORD & CO: 23.98 M
STATE STREET CORP: 18.27 M
SOFTBANK GROUP CORP.: 14.67 M
77.82% of Recursion Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 355.88 M shares in the last 24 months. This purchase volume represents approximately $1.75 B in transactions.